Literature DB >> 32354378

Assessment of Semi-automated Computed Tomographic Measures of Segmental Perfusion Defects in a Swine Model (Sus scrofa) of Intermediate Coronary Lesions.

Bryan C Ramsey1, Amy E Field2, Dustin M Thomas1, Christopher A Pickett1, Alisa J Leon2, Bernard J Rubal3.   

Abstract

Computed tomographic myocardial perfusion (CTP) imaging is a tool that shows promise in emergent settings for defining the hemodynamic significance of coronary artery disease. In this study, we examined the accuracy with which the transmural perfusion ratio (TPR) derived through semiautomated CTP analysis reflected segmental perfusion defects associated with intermediate coronary artery lesions in swine. Lesions (diameter stenosis, 65% ± 11%) of the left anterior descending coronary artery (LAD) were created in 10 anesthetized female swine (weight, 47.5 ± 1.9 kg) by using a pneumatic occlusion device implanted on the LAD. Occluder inflation pressures were adjusted to maintain fractional flow reserve (FFR, 74.3 ± 1.7) during adenosine infusion (140ug/kg/min). Static CTP imaging using a stress-rest protocol and segmental TPR derived from semiautomated CT perfusion software was compared with microsphere-derived TPR (mTPR) by using a 16-segment model and polar mapping. Intermediate LAD stenosis was verified through multiplanar coronary CT angiography. Receiver operating characteristic analysis identified an optimal threshold for segmental perfusion defects for intermediate lesions (TPR threshold, ≤0.80); however, the area under the receiver operating characteristic curve was 0.58, and the overall accuracy was 63%. At this threshold, the sensitivity and specificity were 65% and 61%, and the positive and negative predictive values were 61% and 65%, respectively. Although CTP-TPR illustrated segmental perfusion defects with intermediate lesions, the disparity between CTP-TPR and mTPR measures of segmental perfusion suggests that further advances in analysis software may be necessary to improve the localization of segmental defects for intermediated lesions.

Entities:  

Year:  2020        PMID: 32354378      PMCID: PMC7287383          DOI: 10.30802/AALAS-CM-19-000104

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  29 in total

1.  The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial.

Authors:  James A Goldstein; Kavitha M Chinnaiyan; Aiden Abidov; Stephan Achenbach; Daniel S Berman; Sean W Hayes; Udo Hoffmann; John R Lesser; Issam A Mikati; Brian J O'Neil; Leslee J Shaw; Michael Y H Shen; Uma S Valeti; Gilbert L Raff
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

Review 2.  Integration of coronary anatomy and myocardial perfusion imaging.

Authors:  Ron Blankstein; Marcelo F Di Carli
Journal:  Nat Rev Cardiol       Date:  2010-03-09       Impact factor: 32.419

3.  Computed tomography myocardial perfusion imaging with 320-row detector computed tomography accurately detects myocardial ischemia in patients with obstructive coronary artery disease.

Authors:  Richard T George; Armin Arbab-Zadeh; Julie M Miller; Andrea L Vavere; Frank M Bengel; Albert C Lardo; João A C Lima
Journal:  Circ Cardiovasc Imaging       Date:  2012-03-23       Impact factor: 7.792

4.  Combined coronary angiography and myocardial perfusion by computed tomography in the identification of flow-limiting stenosis - The CORE320 study: An integrated analysis of CT coronary angiography and myocardial perfusion.

Authors:  Tiago A Magalhães; Satoru Kishi; Richard T George; Armin Arbab-Zadeh; Andrea L Vavere; Christopher Cox; Matthew B Matheson; Julie M Miller; Jeffrey Brinker; Marcelo Di Carli; Frank J Rybicki; Carlos E Rochitte; Melvin E Clouse; João A C Lima
Journal:  J Cardiovasc Comput Tomogr       Date:  2015-03-21

Review 5.  Stress myocardial perfusion: imaging with multidetector CT.

Authors:  Alexia Rossi; Daphne Merkus; Ernst Klotz; Nico Mollet; Pim J de Feyter; Gabriel P Krestin
Journal:  Radiology       Date:  2014-01       Impact factor: 11.105

6.  Myocardial CT perfusion imaging and SPECT for the diagnosis of coronary artery disease: a head-to-head comparison from the CORE320 multicenter diagnostic performance study.

Authors:  Richard T George; Vishal C Mehra; Marcus Y Chen; Kakuya Kitagawa; Armin Arbab-Zadeh; Julie M Miller; Matthew B Matheson; Andrea L Vavere; Klaus F Kofoed; Carlos E Rochitte; Marc Dewey; Tan S Yaw; Hiroyuki Niinuma; Winfried Brenner; Christopher Cox; Melvin E Clouse; João A C Lima; Marcelo Di Carli
Journal:  Radiology       Date:  2014-05-26       Impact factor: 11.105

Review 7.  Diagnostic accuracy of static CT perfusion for the detection of myocardial ischemia. A systematic review and meta-analysis.

Authors:  Mathias Holm Sørgaard; Klaus Fuglsang Kofoed; Jesper James Linde; Richard Thomas George; Carlos Eduardo Rochitte; Gudrun Feuchtner; Joao A C Lima; Jawdat Abdulla
Journal:  J Cardiovasc Comput Tomogr       Date:  2016-10-15

Review 8.  Meta-Analysis of Diagnostic Performance of Coronary Computed Tomography Angiography, Computed Tomography Perfusion, and Computed Tomography-Fractional Flow Reserve in Functional Myocardial Ischemia Assessment Versus Invasive Fractional Flow Reserve.

Authors:  Jorge A Gonzalez; Michael J Lipinski; Lucia Flors; Peter W Shaw; Christopher M Kramer; Michael Salerno
Journal:  Am J Cardiol       Date:  2015-08-14       Impact factor: 2.778

9.  Clinical Outcomes After Evaluation of Stable Chest Pain by Coronary Computed Tomographic Angiography Versus Usual Care: A Meta-Analysis.

Authors:  Márcio Sommer Bittencourt; Edward A Hulten; Venkatesh L Murthy; Michael Cheezum; Carlos E Rochitte; Marcelo F Di Carli; Ron Blankstein
Journal:  Circ Cardiovasc Imaging       Date:  2016-04       Impact factor: 7.792

Review 10.  The Updated NICE Guidelines: Cardiac CT as the First-Line Test for Coronary Artery Disease.

Authors:  Alastair J Moss; Michelle C Williams; David E Newby; Edward D Nicol
Journal:  Curr Cardiovasc Imaging Rep       Date:  2017-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.